STAT3 and urinary bladder carcinoma: A study on the STAT3 inhibitor WP1066 demonstrated that when administered at varying doses to bladder cancer cells, WP1066 could block STAT3 phosphorylation, reduce cancer cell survival and proliferation, and induce apoptosis.68